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Fibroproliferative diseases affecting different organs and
systems constitute the largest burden and challenge of
modern medicine. Nearly 45% of all deaths in the devel-
oped world are caused by chronic inflammatory and
fibrogenic disorders such as cardiovascular disease, pul-
monary fibrosis, progressive kidney disease, systemic scle-
rosis, liver cirrhosis and inflammatory bowel disease. In
addition, chronic inflammation and fibrotic tissue
remodelling associated with neo-angiogenesis represent
key mechanisms leading to the development of cancer,
thus accounting for an additional number of deaths.
Regardless of the final clinical outcome, all chronic fibro-
genic disorders have a major impact on the quality of life
of millions of individuals worldwide and represent a
major cost for public health. Despite the massive impact
of fibroproliferative diseases on human health, there are
no approved treatment options that directly target the
mechanisms of fibrosis.
Since research performed over the past thirty years has
made it increasingly clear that fibroproliferative disorders
often share common mechanisms [1,2], encouraging
communication between scientists working in different
subspecialties of experimental or clinical medicine and
the pharmaceutical industry will help identify common
targets and foster the development of new therapeutic
strategies. Accordingly, the main aim of Fibrogenesis & Tis-
sue Repair is to fill the gap in communication which exists
between scientists working on fibrogenesis and tissue
repair in different disciplines, allowing them to exchange
ideas and to work on common targets.
Fibrogenesis & Tissue Repair publishes original and high-
quality research articles providing novel insights into the
mechanisms, diagnosis and treatment of human diseases
characterized by chronic wound healing or fibrogenesis
and leading to end-stage organ failure. In particular, the
journal focuses on the discovery and characterization of
the mechanisms of fibrogenesis and tissue repair common
to, or specific for, different organ systems. Along these
lines, Fibrogenesis & Tissue Repair is divided into five major
fibroproliferative disease areas: gastrointestinal and liver,
renal, rheumatology and connective tissue, lung, heart
and vessels. Particular emphasis is given to those submis-
sions leading to a significant advancement in the fields of
genetic predisposition, diagnostic biomarkers and drug
discovery. The journal also publishes important advance-
ments in the areas of regenerative medicine, cell therapy
and stromal involvement in the genesis of cancer and
metastasis. We also solicit reviews in emerging areas of
research based on suggestions from members of our Edi-
torial Board [3], whose expertise spans a wide range of dis-
ciplines.
Online, open-access publication [4] means that all Fibro-
genesis & Tissue Repair articles will be available to readers
without charge and that movies and animations are only
a click away. The benefits of open access are particularly
pronounced in a journal such as Fibrogenesis & Tissue
Repair that aims to promote the rapid exchange of ideas
between different specialities.
Manuscripts submitted to Fibrogenesis & Tissue Repair will
be reviewed by internationally recognized experts in the
fields of fibrogenesis, inflammation, and tissue regenera-
tion, selected in part from our Editorial Board. Reviews
will be rapid and the suitability of a manuscript for publi-
cation will be assessed solely on criteria of scientific excel-
lence. Upon acceptance, articles will be made
immediately available online and deposited in PubMed
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and PubMed Central. Only once a manuscript is accepted
for publication will the authors be required to pay an Arti-
cle Processing Charge to cover the costs of handling their
manuscript [5]. The authors are not charged extra for col-
our figures and there is no page limit.
We sincerely hope that the scientific community involved
in the study of fibrogenic diseases and, more broadly, in
promoting regenerative medicine will contribute and
respond with renewed enthusiasm to this call. The Editors
are committed to making this new venture a success, and
we hope to receive your contributions in the near future.
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